However, AFE administration markedly inhibited the expression of these NFκB signaling component molecules and JAK2 compared to the AOM/DSS mice, which indicated that AFE could alleviate AOM/DSS-induced CAC by downregulating the NFκB/IL-6/Stat3 and JAK2/Stat3 pathway. Here, NFKB1 is linked to infectious otitis media.